Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
Efficacy and Safety of Combination Treatments for BCC
Experts in dermatology discuss the efficacy and safety combining hedgehog pathway inhibitors and immunotherapy as treatment for patients with basal cell carcinoma.
EP: 1.Insights into Non-Surgical Approaches to Basal Cell Carcinoma
EP: 2.Systemic Treatment Considerations for Basal Cell Carcinoma
EP: 3.Expert Insights into Duration of Treatment for Hedgehog vs Immunotherapy
EP: 4.Key Takeaways and Discussion Highlights
EP: 5.Expert Perspectives in Locally Advanced Basal Cell Carcinoma (BCC) Treatment Options
EP: 6.Developing a Multidisciplinary Approach when Treating BCC
Now Viewing
EP: 7.Efficacy and Safety of Combination Treatments for BCC
EP: 8.Treatment Considerations and Management of Adverse Events when Treating BCC
EP: 9.Use of Systemic Therapy in the Management of Basal Cell Carcinoma
EP: 10.Management of Newly Diagnosed Patients with Basal Cell Carcinoma (BCC)
EP: 11.Expert Insights Into Locally Advanced Basal Cell Carcinoma
EP: 12.Considerations for Hedgehog vs Immunotherapy in Patients with Basal Cell Carcinoma
EP: 13.Frontline Forum Part 1: Improving Basal Cell Carcinoma Management
EP: 14.Frontline Forum Part 2: Improving Basal Cell Carcinoma Management
EP: 15.Frontline Forum Part 3: Improving Basal Cell Carcinoma Management
EP: 16.Frontline Forum Part 4: Improving Basal Cell Carcinoma Management
Related Videos
Related Content
